Catalyst Wire Dossier Catalyst Wire Dossier

Nevirapine (Viramune)

Nevirapine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nevirapine (Viramune), covering 2013-10-31 to 2013-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV [Phase 4]

See pricing